Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion

Citation
Lm. Spyres et al., Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion, INFEC IMMUN, 69(1), 2001, pp. 599-601
Citations number
9
Categorie Soggetti
Immunology
Journal title
INFECTION AND IMMUNITY
ISSN journal
00199567 → ACNP
Volume
69
Issue
1
Year of publication
2001
Pages
599 - 601
Database
ISI
SICI code
0019-9567(200101)69:1<599:CDACOT>2.0.ZU;2-S
Abstract
TcdB from Clostridium difficile glucosylates small GTPases (Rho, pac, and C dc42) and is an important virulence factor in the human disease pseudomembr anous colitis. In these experiments, in-frame genetic fusions between the g enes for the 255 amino-terminal residues of anthrax toxin lethal factor (LF n) and the TcdB(1-556) coding region were constructed, expressed, and purif ied from Escherichia call. LFnTcdB(1-556) was enzymatically active and gluc osylated recombinant RhoA, pac, Cdc42, and substrates from cell extracts. L FnTcdB(1-556) plus anthrax toxin protective antigen intoxicated cultured ma mmalian cells and caused actin reorganization and mouse lethality, all simi lar to those caused by wild-type TcdB.